Release Date: 22/04/10 18:45 Summary: Initial Director's Interest Notice x 3 Price Sensitive: No Download Document 207.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%